New FDA research finds low CBD doses might impact liver health in some people
Cannabidiol, commonly known as CBD, has seen an extraordinary surge in popularity over the past decade, with millions of people turning to this non-psychoactive compound derived from cannabis for relief from anxiety, pain, insomnia, and a wide range of other conditions. However, new findings from a recent study conducted by the U.S. Food and Drug Administration (FDA) are raising fresh concerns about the potential health risks associated with CBD use—specifically its impact on liver function, even at low doses.The investigation, which is integrated into the FDA's continuous assessment of cannabidiol’s safety, indicates that certain people might suffer liver damage or…







